Risk for distant recurrence of breast cancer detected by mammography screening or other methods
- PMID: 15339900
- DOI: 10.1001/jama.292.9.1064
Risk for distant recurrence of breast cancer detected by mammography screening or other methods
Abstract
Context: Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods.
Objective: To compare the risk of recurrence and survival among women with cancerous tumors detected by mammography screening compared with other methods (outside of screening).
Design, setting, and patients: Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n = 2842). The median follow-up time was 9.5 years. Cancer biological variables were analyzed from tumor tissue microarrays using immunohistochemistry or in situ hybridization and included ERBB2, TP53, and MK167 expression and ERBB2 amplification data.
Main outcome measures: Univariate and multivariate analyses of potential risk factors for distant recurrence of breast cancer and 10-year survival.
Results: Of the 1983 women with unilateral invasive breast cancer, data on tumor diameter were available for 1918 women. Women with cancerous tumors detected by mammography screening had better estimated 10-year distant disease-free survival than women with tumors found outside of screening (tumor size of < or =10 mm [n = 386] 92% vs 85% [P =.04]; 11-20 mm [n = 808] 88% vs 76% [P<.001]; 21-30 mm [n = 409] 86% vs 63% [P =.008]; >30 mm [n = 315] 68% vs 50% [P =.12], respectively). In a Cox multivariate model that included cancer biological factors, the relative hazard ratio for distant recurrence among women with tumors detected outside of screening (HR, 1.90; 95% confidence interval, 1.15-3.11) was significantly higher than among women with tumors detected by mammography screening (P =.01). Breast cancer diagnosis by mammography screening was an independent prognostic variable reducing the relative HR for distant recurrence. This effect was equal to or greater than the effect of 1-cm decrease in tumor diameter (HR, 1.20; 95% confidence interval, 1.10-1.31).
Conclusions: Cancerous tumors detected by mammography screening are associated with a better prognosis than tumors of similar size found outside of screening. The risk of distant metastases is overestimated for women diagnosed as having cancer by mammography screening unless the method of detection is taken into account in risk estimations.
Comment in
-
Do tumors detected by mammography screening have a favorable prognosis?JAMA. 2004 Sep 1;292(9):1062-3. doi: 10.1001/jama.292.9.1062. JAMA. 2004. PMID: 15339899 No abstract available.
-
Spontaneous regression of cancerous tumors detected by mammography screening.JAMA. 2004 Dec 1;292(21):2579-80; author reply 2580. doi: 10.1001/jama.292.21.2579. JAMA. 2004. PMID: 15572712 No abstract available.
Similar articles
-
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. APMIS. 2014. PMID: 25046200 Review.
-
Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.Eur J Cancer Prev. 2012 Nov;21(6):499-506. doi: 10.1097/CEJ.0b013e328350b0f4. Eur J Cancer Prev. 2012. PMID: 22273849 Review.
-
Long-term prognosis of breast cancer detected by mammography screening or other methods.Breast Cancer Res. 2011;13(6):R134. doi: 10.1186/bcr3080. Epub 2011 Dec 28. Breast Cancer Res. 2011. PMID: 22204661 Free PMC article.
-
Mammographic screening reduces risk of breast carcinoma recurrence.Cancer. 2005 Feb 1;103(3):474-82. doi: 10.1002/cncr.20793. Cancer. 2005. PMID: 15611974
-
Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589
Cited by
-
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time.J Natl Cancer Inst. 2024 Mar 7;116(3):370-378. doi: 10.1093/jnci/djad230. J Natl Cancer Inst. 2024. PMID: 37935443 Free PMC article.
-
Breast cancer outcomes based on method of detection in community-based breast cancer registry.Breast Cancer Res Treat. 2024 Jan;203(2):215-224. doi: 10.1007/s10549-023-07092-x. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878149
-
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman.J Gen Intern Med. 2023 Aug;38(11):2584-2592. doi: 10.1007/s11606-023-08043-4. Epub 2023 Feb 7. J Gen Intern Med. 2023. PMID: 36749434 Free PMC article.
-
Breast Cancer Screening: Is There Room for De-escalation?Curr Breast Cancer Rep. 2022;14(4):153-161. doi: 10.1007/s12609-022-00465-z. Epub 2022 Nov 7. Curr Breast Cancer Rep. 2022. PMID: 36404936 Free PMC article. Review.
-
Cancer survivors' cancellations of healthcare appointments during the COVID-19 pandemic: Associations with anxiety and depression.Psychooncology. 2022 Dec;31(12):2104-2112. doi: 10.1002/pon.6044. Epub 2022 Oct 12. Psychooncology. 2022. PMID: 36209390 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous